|
Market Closed -
Euronext Paris
11:55:00 2026-10-16 EDT
|
5-day change | 1st Jan Change | ||
| 2.150 EUR | -0.92% |
|
-3.59% | -20.66% |
| 10-01 | Taconic Biosciences, Inc. And genOway Partner To Expand U.S. Access To Advanced Humanized Mouse Models | CI |
| 09-23 | GenOway teams up with Taconic Biosciences to accelerate in the United States |  |
| Market Cap | 19.82M 22.3M 18.37M 16.72M 31.55M 2.12B 32.05M 221M 86.59M 1.1B 83.7M 81.91M 3.52B | P/E 2024 * |
-
| P/E 2025 | - |
|---|---|---|---|---|---|
| Enterprise Value | 26.54M 29.86M 24.6M 22.38M 42.24M 2.83B 42.91M 296M 116M 1.48B 112M 110M 4.71B | EV / Sales 2024 |
1.36x | EV / Sales 2025 | 1.22x |
| Free-Float |
59.02% | Yield 2024 * |
-
| Yield 2025 | - |
Euronext ParisEUR
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| ALGEN | Real-time | |
Deutsche Boerse AG
| JEH | Delayed | |
|
Boerse Muenchen
| JEH | Real-time | |
|
Börse Stuttgart
| JEH | Delayed |
| 1 day | -0.92% | ||
| 1 week | -3.59% | ||
| Current month | -8.12% | ||
| 1 month | -13.31% | ||
| 3 months | -16.34% | ||
| 6 months | -14.00% | ||
| Current year | -20.66% |
| 1 week | 2.09 |  | 2.26 |
| 1 month | 2.01 | | 2.5 |
| Current year | 2.01 | | 2.79 |
| 1 year | 2.01 | | 2.88 |
| 3 years | 2.01 | | 4.91 |
| 5 years | 2.01 | | 4.91 |
| 10 years | 1 | | 7.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Chief Operating Officer | - | 1999-02-28 | |
Benjamin Bruneau
DFI | Director of Finance/CFO | - | 2015-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 1999-02-28 | |
| Chairman | - | - | |
Laurent Fraisse
BRD | Director/Board Member | - | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/20/22 | Buy | Chief Executive Officer | 12,500 | 0.1376% | ||
| 11/17/21 | Sell | Chief Executive Officer | 5,000 | 0.0553% | ||
| 11/13/21 | Sell | Founder | 1,147 | 0.0127% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.92% | -3.59% | -22.38% | -48.19% | 22.3M | |
| -6.60% | -8.56% | +49.38% | +64.90% | 65B | |
| +0.03% | +5.56% | +9.10% | +75.22% | 51.2B | |
| -4.09% | -0.11% | +2.22% | +55.67% | 51.19B | |
| -1.53% | +2.70% | +30.48% | +41.25% | 43.93B | |
| -1.34% | +4.12% | +16.64% | +120.28% | 41.96B | |
| -5.97% | -6.22% | +228.95% | +483.48% | 38.14B | |
| +6.53% | +8.02% | +16.40% | +56.32% | 33.24B | |
| -0.90% | -10.49% | +37.09% | +1.80% | 25.2B | |
| -1.07% | +2.33% | +19.43% | +20.40% | 22.5B | |
| Average | -1.59% | -0.67% | +38.73% | +87.11% | 37.24B | |
| Weighted average by Cap. | -2.20% | -0.50% | +44.24% | +103.64% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 25.84M 29.07M 23.95M 21.79M 41.12M 2.76B 41.78M 288M 113M 1.44B 109M 107M 4.59B | 26.03M 29.28M 24.13M 21.95M 41.42M 2.78B 42.09M 290M 114M 1.45B 110M 108M 4.62B |
| Net income | 1.83M 2.06M 1.7M 1.54M 2.91M 195M 2.96M 20.4M 8M 102M 7.73M 7.56M 325M | 928K 1.04M 860K 782K 1.48M 99.06M 1.5M 10.34M 4.05M 51.69M 3.92M 3.83M 165M |
| Net Debt | 623K 701K 577K 525K 991K 66.51M 1.01M 6.94M 2.72M 34.71M 2.63M 2.57M 111M | 6.72M 7.56M 6.23M 5.67M 10.69M 717M 10.86M 74.85M 29.35M 374M 28.36M 27.76M 1.19B |
Employees
163
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-16 | €2.150 | -0.92% | 681 |
| 26-10-15 | €2.170 | -3.13% | 5,985 |
| 26-10-14 | €2.240 | 0.00% | 763 |
| 26-10-13 | €2.240 | +0.90% | 1,040 |
| 26-10-12 | €2.220 | -0.45% | 6,788 |
- Stock Market
- Stocks
- ALGEN Stock
Select your edition
All financial news and data tailored to specific country editions
